Protagonist Therapeutics Inc
(PTGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,551 | -88,644 | -54,840 | -23,998 | -66,150 |
| Depreciation Amortization | 4,605 | 3,277 | 2,073 | 972 | 2,760 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,438 |
| Accounts receivable | 860 | -212 | -4,651 | -1,570 | 4,329 |
| Accounts payable and accrued liabilities | -3,223 | -3,896 | 13,538 | 3,747 | 1,780 |
| Other Working Capital | -3,314 | -6,930 | -6,285 | -8,390 | -19,016 |
| Other Operating Activity | 18,758 | 15,479 | -2,291 | 483 | 2,375 |
| Operating Cash Flow | $-107,865 | $-80,926 | $-52,456 | $-28,756 | $-72,484 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,101 | -905 | -640 | -140 | -471 |
| Purchase Of Investment | -286,589 | -255,902 | -163,460 | -87,205 | -280,027 |
| Sale Of Investment | 271,830 | 213,080 | 165,080 | 80,552 | 189,533 |
| Investing Cash Flow | $-15,860 | $-43,727 | $980 | $-6,793 | $-90,965 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -14 |
| Debt Repayment | N/A | N/A | N/A | N/A | -10,524 |
| Common Stock Issued | 130,112 | 127,939 | 126,558 | 1,316 | 258,164 |
| Other Financing Activity | -189 | -189 | -189 | -337 | 0 |
| Financing Cash Flow | $129,923 | $127,750 | $126,369 | $979 | $247,626 |
| Exchange Rate Effect | -126 | -148 | -74 | -23 | 175 |
| Beginning Cash Position | 117,818 | 117,818 | 117,818 | 117,818 | 33,466 |
| End Cash Position | 123,890 | 120,767 | 192,637 | 83,225 | 117,818 |
| Net Cash Flow | $6,072 | $2,949 | $74,819 | $-34,593 | $84,352 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107,865 | -80,926 | -52,456 | -28,756 | -72,484 |
| Capital Expenditure | -1,101 | -905 | -640 | -140 | -471 |
| Free Cash Flow | -108,966 | -81,831 | -53,096 | -28,896 | -72,955 |